Also trades as: NIOX.L (LSE) · $vol 1M
CSSPF OTC
NIOX Group Plc
1W: +0.0%
1M: +9.6%
3M: +19.9%
YTD: -2.3%
1Y: -2.3%
3Y: +97.6%
5Y: +205.9%
$0.90
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$378.3M
52W Range0.75-0.92
Volume1,000
Avg Volume40
Beta-0.09
Dividend$0.02
Analyst Ratings
Company Info
CEOJonathan Charles Emms
Employees97
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-02-03
Websiteniox.com
Magdalen Centre
Oxford, OX OX4 4GA
GB
Oxford, OX OX4 4GA
GB
44 18 6540 5560
About NIOX Group Plc
Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.
Recent Insider Trades
No insider trades found